XML 46 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Nature of Business (Details)
3 Months Ended 6 Months Ended
Jun. 19, 2017
USD ($)
position
Jun. 21, 2016
USD ($)
product
Feb. 01, 2016
USD ($)
Jun. 30, 2017
USD ($)
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Jun. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Proceeds from sale of businesses           $ 0 $ 437,875,000  
Contingent purchase price from sale of businesses       $ 143,700,000   143,700,000   $ 143,700,000
Restructuring, Settlement and Impairment Provisions [Abstract]                
Impairment charge       329,097,000 $ 0 329,097,000 0  
Severance and other exits costs $ 5,900,000              
Long-lived assets       715,081,000   715,081,000   $ 1,051,258,000
Decrease in fair value of contingent consideration           4,116,000 $ (1,336,000)  
Discontinued operations, disposed of by sale | Hemostasis Business                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Proceeds from sale of businesses     $ 174,100,000          
Contingent purchase price from sale of businesses     $ 235,000,000 78,000,000   78,000,000    
Not discontinued operations, disposed of by sale | Non-Core ACC Products                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Proceeds from sale of businesses   $ 263,807,000            
Contingent purchase price from sale of businesses   $ 480,000,000   65,700,000   65,700,000    
Number of products sold | product   3            
Payment for release of claims   $ 7,500,000            
Not discontinued operations, discontinuation and market withdrawal | Ionsys                
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Number of positions eliminated | position 57              
Percent of workforce eliminated 15.00%              
Restructuring, Settlement and Impairment Provisions [Abstract]                
Impairment, severance and other employee costs $ 277,000,000              
Impairment charge 268,100,000              
Severance and other exits costs 8,900,000              
Impairment of fixed assets 11,400,000              
Long-lived assets $ 0              
Not discontinued operations, discontinuation and market withdrawal | MDCO-700                
Restructuring, Settlement and Impairment Provisions [Abstract]                
Impairment of indefinite-lived intangible assets       65,000,000        
Decrease in fair value of contingent consideration       14,700,000   14,700,000    
Contingent consideration, carrying value       0   0    
Income tax benefit, disposition       $ 23,000,000   $ 23,000,000